|
業務類別
|
Biotechnology |
|
業務概覽
|
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includesSGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease andother rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States. |
| 公司地址
| 7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650 |
| 電話號碼
| +972 89313433 |
| 傳真號碼
| +972 153523044444 |
| 公司網頁
| https://www.sol-gel.com |
| 員工數量
| 28 |
| Mr. Moshe Arkin |
Executive Chairman of the Board and interim Chief Executive Officer |
-- |
29/04/2025 |
| Dr. Ofer Toledano |
Vice President, Research and Development |
美元 204.00K |
29/04/2025 |
| Dr. Ofra Levy-Hacham |
Vice President, Clinical, Regulatory Affairs and Quality |
美元 172.00K |
29/04/2025 |
| Dr. Itzik Yosef |
Chief Operating Officer |
-- |
29/04/2025 |
| Mr. Michael Glezin |
Chief Business Officer |
-- |
29/04/2025 |
| Ms. Tamar Fishman Jutkowitz |
Vice President and General Counsel |
美元 162.00K |
29/04/2025 |
| Mr. Eyal Ben-Or |
Chief Financial Officer |
-- |
29/04/2025 |
|
|
| Mr. Moshe Arkin |
Executive Chairman of the Board and interim Chief Executive Officer |
29/04/2025 |
| Mr. Ran Gottfried |
Lead Independent Director |
29/04/2025 |
| Mr. Sharon Kochan |
Director |
29/04/2025 |
| Mr. Yuval Yanai |
Independent Director |
29/04/2025 |
| Mr. Itai Arkin |
Director |
29/04/2025 |
| Ms. Hani Lerman |
Director |
29/04/2025 |
|
|
|
|
